Long-Term Complications and Patient-Reported Outcomes After Alloplastic Breast Reconstruction. (March 2022)
- Record Type:
- Journal Article
- Title:
- Long-Term Complications and Patient-Reported Outcomes After Alloplastic Breast Reconstruction. (March 2022)
- Main Title:
- Long-Term Complications and Patient-Reported Outcomes After Alloplastic Breast Reconstruction
- Authors:
- Lee, Chia-Chun
Perng, Cherng-Kang
Ma, Hsu
Wu, Szu-Hsien
Hsiao, Fu-Yin
Tseng, Ling-Ming
Tsai, Yi-Fang
Lin, Yen-Shu
Lien, Pei-Ju
Feng, Chin-Jung - Abstract:
- Abstract : Background: The most widely used method for breast reconstruction in Taiwan is alloplastic breast reconstruction, and traditionally, it can be categorized into immediate or delayed, single-stage or 2-stage procedures. We evaluated clinical outcomes and analyzed patients' self-reported satisfaction and quality of life after alloplastic breast reconstruction based on a previous preliminary study. Patient and Methods: The patients who underwent primary alloplastic breast reconstruction after mastectomy were recruited in 2006 to 2020 at a single institute in Taiwan. The assessment of clinical outcomes was conducted by retrospective chart review and risk analysis. The patients also completed the BREAST-Q, a condition-specific patient-reported outcome measure, at least 6 months after treatment. Results: A total of 237 patients with 247 reconstructed breasts were enrolled in this study. The demographics showed that 205 (83%) were reconstructed using a 2-stage tissue expander-based procedure and 42 (17%) were 1-stage direct-to-implant reconstructions. The mean follow-up time was 79.5 months. The clinical assessment revealed that the overall complication rate was 34%, with infection being the most common (21 patients; 8%). According to risk analysis, smoking (odds ratio, 7.626; 95% confidence interval, 1.56–37.30; P = 0.012), and nipple-sparing mastectomy (odds ratio, 3.281; 95% confidence interval, 1.54–6.99; P = 0.002) were significant risk factors for overallAbstract : Background: The most widely used method for breast reconstruction in Taiwan is alloplastic breast reconstruction, and traditionally, it can be categorized into immediate or delayed, single-stage or 2-stage procedures. We evaluated clinical outcomes and analyzed patients' self-reported satisfaction and quality of life after alloplastic breast reconstruction based on a previous preliminary study. Patient and Methods: The patients who underwent primary alloplastic breast reconstruction after mastectomy were recruited in 2006 to 2020 at a single institute in Taiwan. The assessment of clinical outcomes was conducted by retrospective chart review and risk analysis. The patients also completed the BREAST-Q, a condition-specific patient-reported outcome measure, at least 6 months after treatment. Results: A total of 237 patients with 247 reconstructed breasts were enrolled in this study. The demographics showed that 205 (83%) were reconstructed using a 2-stage tissue expander-based procedure and 42 (17%) were 1-stage direct-to-implant reconstructions. The mean follow-up time was 79.5 months. The clinical assessment revealed that the overall complication rate was 34%, with infection being the most common (21 patients; 8%). According to risk analysis, smoking (odds ratio, 7.626; 95% confidence interval, 1.56–37.30; P = 0.012), and nipple-sparing mastectomy (odds ratio, 3.281; 95% confidence interval, 1.54–6.99; P = 0.002) were significant risk factors for overall complications. The questionnaire response rate was 38% (94 of 247), at least 6 months after treatment. The total mean score was 69.78. Conclusions: At a single institute in Taiwan from 2006 to 2020, alloplastic breast reconstruction, either single- or 2-stage, have acceptable complication rate and good postoperative satisfaction based on patient-reported outcomes. Both patient- and surgery-related factors presented as significant risk factors. Precise patient selection and comprehensive discussion between the patient and physician may play the important role to achieve optimal aesthetic outcomes. … (more)
- Is Part Of:
- Annals of plastic surgery. Volume 88(2022)Supplement 1S
- Journal:
- Annals of plastic surgery
- Issue:
- Volume 88(2022)Supplement 1S
- Issue Display:
- Volume 88, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 88
- Issue:
- 1
- Issue Sort Value:
- 2022-0088-0001-0000
- Page Start:
- S78
- Page End:
- S84
- Publication Date:
- 2022-03
- Subjects:
- breast reconstruction -- breast implant -- patient-reported outcomes
Surgery, Plastic -- Periodicals
617.95205 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00000637-000000000-00000 ↗
http://www.annalsplasticsurgery.com ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/SAP.0000000000003114 ↗
- Languages:
- English
- ISSNs:
- 0148-7043
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1043.525000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20884.xml